Nuvectis Pharma Inc. (NASDAQ: NVCT)
$6.1100
-0.0600 ( -2.71% ) 79.2K
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Market Data
Open
$6.1100
Previous close
$6.1700
Volume
79.2K
Market cap
$119.21M
Day range
$5.9600 - $6.7300
52 week range
$4.4400 - $12.1000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 48 | May 07, 2024 |
| def | Proxies and info statements | 6 | Apr 29, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 8-k | 8K-related | 16 | Mar 05, 2024 |
| 10-k | Annual reports | 80 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Jan 05, 2024 |
| 4 | Insider transactions | 1 | Jan 05, 2024 |